Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy

In order to track the evolution of primary protease inhibitor (PI) resistance mutations in human immunodeficiency virus type 1 (HIV-1) isolates, baseline and follow-up protease sequences were obtained from patients undergoing salvage PI therapy who presented initially with isolates containing a sing...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kantor, Rami, Fessel, W. Jeffrey, Zolopa, Andrew R., Israelski, Dennis, Shulman, Nancy, Montoya, Jose G., Harbour, Michael, Schapiro, Jonathan M., Shafer, Robert W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2002
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC127108/
https://ncbi.nlm.nih.gov/pubmed/11897594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.4.1086-1092.2002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak